A synthetic analogue of LSD, with lower hallucinogenic potential, could open new options to treat schizophrenia.

Google News RSS

• https://news.google.com/rss/search?q=a-synthetic-analogue-of-lsd-with-lower-hallucinogenic-potential-could-open-new-options-to-treat-schizophrenia

Latest Articles Fetched Here

• Researchers Develop an LSD Analogue with Potential for Treating Schizophrenia  UC Davis
• An LSD analogue for treating psychiatric diseases  National Institutes of Health (.gov)
• Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential  PNAS
• LSD Analog That May Have Potential for Treating Schizophrenia Developed  Genetic Engineering and Biotechnology News
• Scientists Redesign LSD To Create a Non-Hallucinogenic Antidepressant  Technology Networks
• Scientists Flip Two Atoms in LSD – And Unlock a Game-Changing Mental Health Treatment  SciTechDaily
• Clinical trial explores the power of psilocybin to treat depression  UCHealth
• New LSD-like drug could revolutionize mental health treatment  AOL.com
• Psychedelics without the hallucinations: A new mental health treatment? with David E. Olson  University of Chicago News
• Towards an understanding of psychedelic-induced neuroplasticity | Neuropsychopharmacology  Nature
• Biological studies of clavine alkaloids targeting CNS receptors  Frontiers
• Psychedelic Drugs Market Size, Share & Trends | Global Outlook  SNS Insider
• Can Psychedelics Treat Chronic Pain?  HealthCentral
• Medication Pipeline: Antidepressants and ADHD Rx  Psychiatric Times
• Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So.  lucid.news
• New Compound Related to Psychedelic Ibogaine Could Treat Addiction, Depression  UC Davis
• 1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?  Frontiers
• An Introduction to Five Psychedelics: Psilocybin, DMT, LSD, MDMA and Ketamine  Technology Networks
• Psychedelic Stocks & Companies  Psychedelic Alpha